Grb2 overexpression in nuclei and cytoplasm of human breast cells: A histochemical and biochemical study of normal and neoplastic mammary tissue specimens

Journal of Pathology

Volumn 183, Issue 2, 1997, Pages 195-203

  Verbeek, Bianca S ^a   Adriaansen Slot, Sabrina S ^a   Rijksen, Gert ^a   Vroom, Thea M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Breast cancer; Grb2; Nuclear localization; Overexpression

Indexed keywords

BINDING PROTEIN; GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; RECEPTOR PROTEIN;

ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RECEPTOR DENSITY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BREAST; BREAST NEOPLASMS; CELL NUCLEUS; CYTOPLASM; FEMALE; GENE EXPRESSION; GRB2 ADAPTOR PROTEIN; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; NEOPLASM PROTEINS; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0030867556     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199710)183:2<195::AID-PATH901>3.0.CO;2-Y     Document Type: Article

References (38)

1. Cantley LC, Auger KR, Carpenter C, et al. Oncogenes and signal transduction. Cell 1991; 64: 281-302.
2. Schlessinger J, Ullrich A. Growth factor signalling by receptor tyrosine kinases. Neuron 1992; 9: 383-391.
3. Koch CA, Anderson D, Moran MF, Ellis C, Pawson T. SH2 and SH3 domains: elements that control interactions of cytoplasmic signalling proteins. Science 1991; 252: 668-674.
4. Margolis B, Rhee SG, Felder S, et al. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signalling. Cell 1989; 57: 1101-1107.
5. Kaplan DR, Morrison DK, Wong G, McCormick F, Williams LT. PDGF β-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signalling complex. Cell 1990; 61: 125-133.
6. Kypta RM, Goldberg Y, Ulug ET, Courtneidge SA. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell 1990; 62: 481-492.
7. Chardin P, Cussac D, Maignan S, Ducruix A. The Grb2 adaptor. FEBS Lett 1995; 369: 47-51.
8. Kapeller R, Cantley LC. Phosphatidylinositol 3-kinase. Bioessays 1994; 16: 565-576.
9. Lowenstein EJ, Daly RJ, Batzer AG, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signalling. Cell 1992; 70: 431-442.
10. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 1993; 363: 4551-4553.
11. Matuoka K, Shibata M, Yamakawa A, Takenawa T. Cloning of ASH, a ubiquitous protein composed of one Src homology region (SH) 2 and two SH3 domains from human and rat cDNA libraries. Proc Natl Acad Sci USA 1992; 89: 9015-9019.
12. Nobes CD, Hall A. Rho, Rac and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia and filopodia. Cell 1995; 81: 53-62.
13. Matuoka K, Shibasaki F, Shibata M, Takenawa T. Ash/Grb2, an SH2/ SH3-containing protein, couples to signalling for mitogenesis and cytoskeletal reorganization by EGF and PDGF. EMBO J 1993; 12: 3467-3473.
14. Bar-Sagi D, Rotin D, Batzer A, Mandiyan V, Schlessinger J. SH3 domains direct cellular localization of signalling molecules. Cell 1993; 74: 83-91.
15. Sainsbury JRC, Sherbet GV, Farndon JR, Harris AL. Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet 1985; 2: 364-366.
16. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of HER-2/Neu oncogene. Science 1987; 235: 177-182.
17. Bonneterre J, Peyrat JP, Beuscart R, Demaille A. Prognostic significance of insulin-like growth factor I receptors in human breast cancer. Cancer Res 1990; 50: 6931-6935.
18. Papa V, Pezzino V, Constantino A, et al. Elevated insulin receptor content in human breast cancer. J Clin Invest 1990; 86: 1503-1510.
19. Pelicci G, Lanfrancone L, Grigani F, et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992; 70: 93-104.
20. Chou MM, Fajardo JE, Hanafusa H. The SH2-and SH3-containing Nek protein transforms mammalian fibroblasts in the absence of elevated phosphotyrosine levels. Mol Cell Biol 1992; 12: 5834-5842.
21. Daly RJ, Binder MD, Sutherland RL. Overexpression of the Grb2 gene in human breast cancer cell lines. Oncogene 1994; 9: 2723-2727.
22. Clark GJ, Der CJ. Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res Tr 1995; 35: 133-144.
23. Suen KL, Bustelo XR, Pawson T, Barbacid M. Molecular cloning of the mouse grb2 gene: differential interaction of the Grb2 adaptor protein with epidermal growth factor and nerve growth factor receptors. Mol Cell Biol 1993; 13: 5500-5512.
24. Tanaka M, Gupta R, Mayer BJ. Differential inhibition of signalling pathways by dominant-negative SH2/SH3 adaptor proteins. Mol Cell Biol 1995; 15: 6829-6837.
25. Verbeek BS, Vroom TM, Ottenhoff-Kalff AE, et al. c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol (in press).
26. Leede van der B-J, Geertzema JGN, Vroom TM, et al. Immunohistochemical analysis of retinoic acid receptor-alpha in human breast tumors. Retinoic acid receptor-alpha expression correlates with proliferative activity. Am J Pathol 1996; 148: 1905-1914.
27. Lee KAW, Bindereif A, Green MR. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal Techn 1988; 5: 22-31.
28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
29. Beutler E. Red Cell Metabolism. A Manual of Biochemical Methods. 2nd edn. New York: Grune and Stratton, 1975.
30. Rijksen G, van Oirschot BA, Staal GEJ. Nonradioactive assays of proteintyrosine kinase activity using anti-phosphotyrosine antibodies. In: Hunter T, Sefton BM, eds. Methods in Enzymology, Volume 200. San Diego, CA: Academic Press, 1991; 98-107.
31. Hubbard AL, Wall DA, Ma A. Isolation of rat hepatocyte plasma membranes. I. Presence of three major domains. J Cell Biol 1983; 96: 217-229.
32. Sanui H. Measurements of inorganic orthophosphate in biological materials: extraction properties of butyl acetate. Anal Biochem 1974; 60: 489-504.
33. Janes PW, Daly RJ, deFazio A, Sutherland RL. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB2. Oncogene 1994; 9: 3601-3608.
34. Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J, Bar-Sagi D. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 1993; 363: 88-92.
35. Downward J. The GRB2 Sem-5 adaptor protein. FEBS Lett 1994; 338: 113-117.
36. Zhu X, Suen KL, Barbacid M, Bolen JB, Fargnoli J. Interleukin-2-induced tyrosine phosphorylation of Shc proteins correlates with factor-dependent T cell proliferation. J Biol Chem 1994; 269: 5518-5522.
37. Buday L, Egan SE, Rodriguez-Viciana P, Cantrell DA, Downward J. A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells. J Biol Chem 1994; 269: 9019-9023.
38. Wang JYJ. Nuclear protein tyrosine kinases. TIBS 1994; 19: 373-376.